Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat use of Picato 0.05% for anogenital warts
2014-004465-24Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Dec 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ingenol mebutate in anogenital warts, sponsored by LEO Pharma. Primary endpoint: Incidence and severity of local skin reactions and treatment-related adverse events. Started Dec 2014; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
anogenital warts
Beyond the preview
Go deeper on 2014-004465-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004465-24.